A Multi-Institution Phase I Trial of Ruxolitinib in Patients with Chronic Myelomonocytic Leukemia (CMML)

Overview of attention for article published in Clinical Cancer Research, July 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 14,121 followers.

Our first clinical trial from the MDS clinical research consortium Phase 1 Trial of Ruxolitinib in Patients CMML https://t.co/CPuyx4mvO9

RT @CancerCureNow: A Multi-Institution Phase 1 Trial of Ruxolitinib in Patients with Chronic Myelomonocytic Leukemia (CMML) https://t.co/9…

A Multi-Institution Phase 1 Trial of Ruxolitinib in Patients with Chronic Myelomonocytic Leukemia (CMML) https://t.co/98IlmBaSUE

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.